Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The melatonin agonist VEC-162 immediately phase-advances the human circadian system

The melatonin agonist VEC-162 immediately phase-advances the human circadian system. Sleep. 2006; (in press).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.